1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Shanghai Junshi Biosciences Co., Ltd.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2012

Location

Shanghai China

Primary Industry

Biotechnology

About

Based in Shanghai, China and established in 2012, Shanghai Junshi Biosciences Co., Ltd. is a biopharmaceutical company that focuses on the discovering and development of monoclonal antibody drugs. The company has four research and development centers in Shanghai and Suzhou, San Francisco and Maryland, and two production sites in Suzhou and Shanghai. The CEO of the company, Dr. Ning Li, worked in U.S. Food and Drug Administration. In December 2015, Junshi Biosciences received IND approval for its anti-PD-1 monoclonal antibody drug. The company has established a number of core technology platforms, such as monoclonal hybridoma, screening and evaluation of candidate antibodies, humanization, and construction and screening system of mammalian cells with high expression of monoclonal drugs. Junshi has developed 28 innovative drugs, 2 bioanalogues including PD-1 monoclonal antibody (JS001), PCSK9 monoclonal antibody (JS002) and BTLA monoclonal antibody (JS004). The products can be used in tumor, metabolism, autoimmune, nervous system, anti-infection and other major diseases.
Current Investors
Hillhouse Investment, Origin Capital, Apricot Capital

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.junshipharma.com
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.